Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia

$500 SAVINGS END IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan
BOOK NOW
Menu
BOOK NOW

Jyothsna Visweswaraiah
Senior Director, Drug Creation at Seismic Therapeutics, USA
Speaker

Profile

Jyothsna is a scientific leader with deep expertise in biologics discovery and engineering and advancing programs from early R&D through to IND enabling studies. She currently heads the Drug Creation department at Seismic Therapeutic.

Agenda Sessions

  • S-4321, a novel non-depleting bifunctional PD-1:FcγRIIb agonist, for treatment of immune mediated diseases

    , 11:00
    View Session

At this event

Prev
Next
Taichi Kuramochi
Head of Biologics Discovery
Chugai Pharmaceutical, Japan

See Jyothsna at Antibody Engineering & Therapeutics Asia

BOOK NOW